High-end Chinese herbal medicine supplier, focusing on the cultivation of medicinal materials, processing of traditional Chinese medicine decoction pieces, traditional Chinese medicine extraction and prescription preparations, and drug sales
Anhui Yuanhetang Pharmaceutical Co., Ltd. was established in 2003, completed the shareholding system reform in 2010, and since 2012, it has successively introduced China Galaxy Investment, Guangzhou Yuexiu Investment, Shanghai Zhenghai Guoxinyuan Fund, Guangdong Oriental Huiyin Investment and China Sinopharm Group Sinopharm Capital, and Sinopharm has become the second largest shareholder of Yuanhetang Pharmaceutical. At present, Yuanhe Pharmaceutical has developed into a large-scale pharmaceutical enterprise with a whole industry chain of centralized medicinal material cultivation (GAP), processing and sales of decoction pieces (GMP), production of Chinese patent medicines, and pharmaceutical logistics and distribution (GSP).
Since 2013, since 2015, the formula granule project in cooperation with Anhui University of Traditional Chinese Medicine and Hefei Tianyuan Pharmaceutical Research Institute has basically completed more than 8,200 square meters of civil engineering of the main workshop, with a budget investment of about 180 million yuan, and can be put into trial production in the second half of next year, with an annual output of 2,500 tons of 660 varieties of formula granules.
In 2012, from a strategic point of view, the company decided to invest in the upstream planting of Chinese herbal medicines. At present, it has 6,000 acres of planting base, in addition to planting a large area of local authentic medicinal materials, including more than 500 acres of high-grade Chinese medicinal materials saffron, 50 acres of Ganoderma lucidum, and 30 acres of Dendrobium officinalis. According to the company's planning for saffron planting, the saffron planting scale can reach 2,000 acres in 2020, relying on the saffron planted in the base, and the deep processing of saffron should be highly efficient, for which the company cooperated with the School of Pharmacy of Zhejiang University in early 2016 and launched saffron series products at the end of 2017.
At the end of November 2016, the Saffron Research Center was established. Research and popularization and application of saffron bulb diameter rejuvenation and yield enhancement technology, saffron flower picking, ultra-low temperature freeze-drying and storage; Research on the application of saffron in food and functional food; In-depth research on indoor soilless cultivation of saffron and saffron pharmacology.
In short, in the future, Anhui Yuanhetang will work hard in the planting and deep processing of Chinese herbal medicines, high-end Chinese medicine decoction pieces, health food and new special Chinese medicine preparations, and become the industry leader of the Chinese medicine industry!
